Dr. Kyriakopoulos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 Highland Ave
Madison, WI 53792Phone+1 608-265-1700
Education & Training
University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 2010 - 2013
Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 2007 - 2010
Aristotle University of Thessaloniki School of MedicineClass of 2003
Certifications & Licensure
WI State Medical License 2014 - 2025
FL State Medical License Active through 2014
OH State Medical License 2013 - 2014- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Pilot Trial of Chemohormonal Therapy Followed by Prostatectomy in High Risk Prostate Cancer Start of enrollment: 2018 Jan 17
- Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Start of enrollment: 2018 Apr 26
- A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley) Start of enrollment: 2022 Aug 17
Roles: Principal Investigator
Publications & Presentations
PubMed
- 39 citationsActive surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC)Michael R. Harrison, Brian A. Costello, Nrupen A. Bhavsar, Ulka N. Vaishampayan, Sumanta K. Pal
Cancer. 2021-07-01 - 605 citationsChemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED TrialChristos Kyriakopoulos, Yu-Hui Chen, Michael A. Carducci, Glenn Liu, David F. Jarrard
Journal of Clinical Oncology. 2018-01-31 - 255 citationsTROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Ch...Scott T. Tagawa, Arjun Vasant Balar, Daniel P. Petrylak, Arash Rezazadeh Kalebasty, Yohann Loriot
Journal of Clinical Oncology. 2021-04-30
Journal Articles
- Treatment Selection for Men with Metastatic Prostate Cancer Who Progress on Upfront Chemo‐Hormonal TherapyVadim Koshkin, Prateek Mendiratta, Brian I Rini, Pedro Barata, Christos Kyriakopoulos, Hamid Emamekhoo, Timothy Gilligan, The Prostate
Lectures
- A phase I dose escalation study of PCUR-101 in men with metastatic castration-resistant prostate cancer (mCRPC).ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
- Interlesional response assessment with F-sodium fluoride (F-NaF) PET/CT in men with chemotherapy-naive bone metastatic castration-resistant prostate cancer (mCRPC) tre...ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019
Press Mentions
ESSA Pharma Presents Updated Phase 1/2 Masofaniten (EPI-7386) Clinical Data at the 2024 ESMO CongressSeptember 14th, 2024- ERS: Anti-IL-6 Receptor mAb Reduces Covid-19 MortalitySeptember 9th, 2021
Carbone Experts Present Latest Research at World's Largest Cancer MeetingMay 31st, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
